tiprankstipranks
Trending News
More News >
Kazia Therapeutics Limited (KZIA)
NASDAQ:KZIA
US Market

Kazia Therapeutics (KZIA) Ratios

Compare
325 Followers

Kazia Therapeutics Ratios

KZIA's free cash flow for Q2 2025 was AU$1.00. For the 2025 fiscal year, KZIA's free cash flow was decreased by AU$ and operating cash flow was AU$-420.30. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 25Dec 24Dec 23
Liquidity Ratios
Current Ratio
0.21- 0.24 1.42 1.62
Quick Ratio
0.21- 0.24 1.93 1.62
Cash Ratio
0.19- 0.06 0.69 1.57
Solvency Ratio
-1.00- -0.79 -1.16 -1.40
Operating Cash Flow Ratio
-0.45- -0.37 -2.00 -4.86
Short-Term Operating Cash Flow Coverage
-52.98- -15.11 -8.44 -12.36
Net Current Asset Value
AU$ -18.31M-AU$ -25.46MAU$ -5.26MAU$ -8.71M
Leverage Ratios
Debt-to-Assets Ratio
<0.01- 0.03 0.06 0.05
Debt-to-Equity Ratio
-0.04- -0.06 0.15 0.10
Debt-to-Capital Ratio
-0.04- -0.07 0.13 0.09
Long-Term Debt-to-Capital Ratio
0.00- 0.00 0.00 0.00
Financial Leverage Ratio
-4.70- -2.15 2.33 1.88
Debt Service Coverage Ratio
-163.40- -41.79 -12.55 -12.56
Interest Coverage Ratio
0.00- 0.00 0.00 -12.75K
Debt to Market Cap
<0.01- 0.08 0.56 0.23
Interest Debt Per Share
0.17- 1.32 0.97 1.39
Net Debt to EBITDA
0.13- 0.04 0.15 0.23
Profitability Margins
Gross Profit Margin
100.00%-100.00%100.00%100.00%
EBIT Margin
-973.57%--1240.68%-4350725.59%-101536916.00%
EBITDA Margin
-917.33%--1159.71%-4013885.95%-94059236.00%
Operating Profit Margin
-580.77%--1233.19%-4346661.08%-106785308.00%
Pretax Profit Margin
-575.40%--1171.97%-3736265.23%-100063580.00%
Net Profit Margin
-930.18%--1160.23%-3687419.82%-98591260.00%
Continuous Operations Profit Margin
-935.62%--1160.23%-3687419.82%-100056220.00%
Net Income Per EBT
161.66%-99.00%98.69%98.53%
EBT Per EBIT
99.08%-95.04%85.96%93.71%
Return on Assets (ROA)
-129.42%--124.06%-72.87%-70.51%
Return on Equity (ROE)
335.37%-267.33%-169.83%-132.24%
Return on Capital Employed (ROCE)
-1034.15%-675.74%-117.56%-88.18%
Return on Invested Capital (ROIC)
-948.54%-787.50%-109.52%-81.91%
Return on Tangible Assets
-672.57%--432.95%-189.22%-165.32%
Earnings Yield
-115.14%--342.80%-637.93%-305.87%
Efficiency Ratios
Receivables Turnover
28.18- 17.35 0.91 <0.01
Payables Turnover
0.00- 0.00 0.00 0.00
Inventory Turnover
0.00- 0.00 0.00 0.00
Fixed Asset Turnover
0.00- 0.00 0.00 0.00
Asset Turnover
0.14- 0.11 <0.01 <0.01
Working Capital Turnover Ratio
-0.15- -0.28 <0.01 <0.01
Cash Conversion Cycle
12.95- 21.03 401.17 744.60K
Days of Sales Outstanding
12.95- 21.03 401.17 744.60K
Days of Inventory Outstanding
0.00- 0.00 0.00 0.00
Days of Payables Outstanding
0.00- 0.00 0.00 0.00
Operating Cycle
12.95- 21.03 401.17 744.60K
Cash Flow Ratios
Operating Cash Flow Per Share
-8.77- -19.98 -8.22 -17.18
Free Cash Flow Per Share
-8.77- -19.98 -8.22 -17.18
CapEx Per Share
0.00- 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00- 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00- 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
0.00- 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
-52.98- -15.11 -8.44 -12.36
Operating Cash Flow to Sales Ratio
-2.99- -4.15 -27.31K -910.44K
Free Cash Flow Yield
-19.44%--122.65%-47.24%-28.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.92- -0.29 -0.16 -0.33
Price-to-Sales (P/S) Ratio
16.25- 3.38 5.78K 322.34K
Price-to-Book (P/B) Ratio
-5.58- -0.78 0.27 0.43
Price-to-Free Cash Flow (P/FCF) Ratio
-5.43- -0.82 -0.21 -0.35
Price-to-Operating Cash Flow Ratio
-2.85- -0.82 -0.21 -0.35
Price-to-Earnings Growth (PEG) Ratio
-0.04- 0.00 <0.01 >-0.01
Price-to-Fair Value
-5.58- -0.78 0.27 0.43
Enterprise Value Multiple
-1.64- -0.25 0.01 -0.11
Enterprise Value
35.43M- 6.79M 28.64M 75.06M
EV to EBITDA
-1.55- -0.25 -1.29 -3.19
EV to Sales
14.22- 2.94 51.60K 3.00M
EV to Free Cash Flow
-4.75- -0.71 -1.89 -3.30
EV to Operating Cash Flow
-4.75- -0.71 -1.89 -3.30
Tangible Book Value Per Share
-21.49- -53.00 -2.83 -1.07
Shareholders’ Equity Per Share
-4.48- -20.89 6.54 14.07
Tax and Other Ratios
Effective Tax Rate
>-0.01- 0.01 -0.01 0.01
Revenue Per Share
2.93- 4.81 <0.01 <0.01
Net Income Per Share
-27.26- -55.83 -11.11 -18.61
Tax Burden
1.62- 0.99 0.99 0.99
Interest Burden
0.59- 0.94 0.86 0.99
Research & Development to Revenue
6.10- 7.53 28.04K 810.09K
SG&A to Revenue
4.64- 5.88 15.46K 180.46K
Stock-Based Compensation to Revenue
0.13- 0.23 2.09K 67.00K
Income Quality
0.32- 0.36 0.74 0.92
Currency in AUD